Related Experiment Video

Updated: Jul 27, 2025

Sequential Salt Extractions for the Analysis of Bulk Chromatin Binding Properties of Chromatin Modifying Complexes
07:41

Sequential Salt Extractions for the Analysis of Bulk Chromatin Binding Properties of Chromatin Modifying Complexes

Published on: October 2, 2017

8.4K

Essential role of bromodomain proteins in renal cell carcinoma (Review)

Qianghai Wen1, Haicheng Liu1, Kecheng Lou1

  • 1Department of Urology, The First Affiliated Hospital of Gannan Medical University, Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China.

Molecular Medicine Reports
|June 9, 2023
PubMed

Insights

Bromodomain proteins (BRD) regulate histone acetylation, a key factor in kidney cancer. This review explores BRD proteins as potential therapeutic targets for advanced renal cell carcinoma (RCC) due to limited treatment options.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Histone alterations are characteristic of kidney cancer.
  • Bromodomain proteins (BRD) mediate histone acetylation, implicated in various cancers.
  • Renal cell carcinoma (RCC) shows limited sensitivity to conventional therapies, necessitating novel adjuvant treatments.

Approach:

  • This review synthesizes current research on bromodomain family proteins in RCC.
  • It examines the known roles and potential functions of BRD proteins in renal cell carcinoma.
  • The focus is on identifying BRD proteins as potential targets for novel therapeutic strategies.

Key Points:

  • Bromodomain proteins are crucial regulators of gene transcription through histone acetylation.
  • Dysregulation of BRD proteins is observed in several cancer types, including kidney cancer.
  • Targeted inhibition of BRD proteins has shown promise in preclinical cancer models.

Conclusions:

  • Bromodomain proteins represent a promising area for therapeutic development in advanced RCC.
  • Further elucidation of BRD protein functions in RCC is critical for drug discovery.
  • Targeting BRD proteins could offer a novel adjuvant therapy for patients with renal cell carcinoma.
Keywords:
biomarkersbromodomainoncogenerenal cell carcinomatumor suppressor

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.2K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.3K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.3K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.0K